Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internati...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 0.0% | ||
| P/E Ratio | -4.0x | ||
| Revenue | 799.5 M | ||
| Net Income to Company | -126 M |
| OFIX | Peers | Sector | |
|---|---|---|---|
Market Cap | 508.5 M | 521.5 M | 64.048 M |
Price % of 52 Week High | 62.9% | 54.4% | 60.4% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | -11.9% | -0.2% | -0.7% |
1 Year Price Total Return | -0.5% | -22.1% | -12.3% |
Beta (5 Year) | 1.00 | 1.02 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 461 | 747 | 799 | 200 | 216 |
| Operating Income | (30) | (106) | (66) | (12) | (7.74) |
| Net Profit | (20) | (151) | (126) | (22) | (29) |
| Diluted EPS | -0.98 | -4.12 | -3.30 | -0.59 | -0.75 |
| EBITDA | 1.61 | (45) | 10 | 5.08 | 20 |
| Balance Sheet | |||||
| Cash & ST Invest. | 51 | 33 | 83 | 33 | 83 |
| Current Assets | 256 | 420 | 433 | 420 | 433 |
| Total Assets | 459 | 925 | 893 | 925 | 893 |
| Current Liabilities | 84 | 165 | 169 | 165 | 169 |
| Total Liabilities | 122 | 327 | 390 | 327 | 390 |
| Total Equity | 337 | 599 | 503 | 599 | 503 |
| Total Debt | 27 | 134 | 194 | 134 | 194 |
| Cash Flow Statement | |||||
| Cash Flow Operations | (12) | (46) | 26 | (6.69) | 24 |
| Cash From Investing | (25) | (33) | (28) | (15) | (1.14) |
| Cash From Financing | (0.08) | 65 | 51 | 25 | 31 |
| Free Cash Flow | (35) | (108) | (9.09) | (23) | 14 |